Relapsing-Remitting Multiple Sclerosis Patients On Dimethyl Fumarate Reported Less Physical And Psychological Disease Impact In The Real World Compared With Patients On Platform Therapies
Abstract
Authors
M Huang J Pike W Huang E Jones